Serum Lipid Variation in Patients with Dengue Virus Infection and Associated Risks of Cardio Vascular Disorder

Main Article Content

Maira Awan
Kaleem Maqsood
Shaaf Ahmad
Husna Ahmad
Muhammad Amir Iqbal
Nabila Roohi


Background: Dengue virus (DENV) is a most prevalent arbovirus with about 100 million infections worldwide every year. It is endemic in the subtropical and tropical areas in the world, an emerging public health threat. Serum lipidome is a key player in the immune system response of the patient for the period of dengue fever. This study was aimed to assess the lipids deviations in serum of patients with dengue fever.

Materials and Methods: Three For this case-control study blood samples of N=65 dengue patients of age 18 year were collected from the Mayo Hospital, Lahore. Whereas samples of 45 healthy individuals were collected from the University of the Punjab, Lahore. Blood samples from subjects were collected to analyze serum lipidome.

Results: Significantly (P < 0.001) increased serum triglyceride, total cholesterol, low density lipoprotein, and very low-density lipoprotein while a significant (P < 0.001) reduction in high density lipoprotein was observed in the dengue patient’s serum in contrast to the control.

Conclusion: We can conclude that DENV infection can contribute to dyslipidemia with subsequent cardiovascular disorder symptoms. Therefore, patients infected with DENV should monitor their serum lipid profiles to deal with DENV induced effects to the cardiovascular physiology.

Article Details

How to Cite
Awan, M., Maqsood, K., Ahmad, S., Ahmad, H., Iqbal, M. A., & Roohi, N. (2022). Serum Lipid Variation in Patients with Dengue Virus Infection and Associated Risks of Cardio Vascular Disorder. Albus Scientia, 2022(2), 1–4.


Bruckert, E., & Hansel, B. (2007). HDL-c is a powerful lipid predictor of cardiovascular diseases. International Journal of Clinical Practice, 61(11), 1905–1913.

Castelli W. P. (1988). Cardiovascular disease in women. American Journal of Obstetrics and Gynecology, 158(6), 1553–1567.

Coelho, D. R., Carneiro, P. H., Mendes-Monteiro, L., Conde, J. N., Andrade, I., Cao, T., Allonso, D., White-Dibiasio, M., Kuhn, R. J., & Mohana-Borges, R. (2021). ApoA1 neutralizes proinflammatory effects of dengue virus ns1 protein and modulates viral immune evasion. Journal of Virology, 95(13), e0197420.

Durán, A., Carrero, R., Parra, B., González, A., Delgado, L., Mosquera, J., & Valero, N. (2015). Association of lipid profile alterations with severe forms of dengue in humans. Archives of Virology, 160(7), 1687–1692.

Félix-Redondo, F. J., Grau, M., & Fernández-Bergés, D. (2013). Cholesterol and cardiovascular disease in the elderly. Facts and gaps. Aging and Disease, 4(3), 154–169.

Friedewald, W. T., Levy, R. I., & Fredrickson, D. S. (1972). Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clinical Chemistry, 18(6), 499–502.

Gloria-Soria, A., Brown, J. E., Kramer, V., Hardstone Yoshimizu, M., & Powell, J. R. (2014). Origin of the dengue fever mosquito, Aedes aegypti, in California. PLoS Neglected Tropical Diseases, 8(7), e3029.

Higa Y. (2011). Dengue Vectors and their Spatial Distribution. Tropical Medicine and Health, 39(4 Suppl), 17–27.

Hoogeveen, R. C., & Ballantyne, C. M. (2021). Residual cardiovascular risk at low LDL: Remnants, lipoprotein(a), and inflammation. Clinical Chemistry, 67(1), 143–153.

Kuller, L. H., & Women's Health Initiative (2003). Hormone replacement therapy and risk of cardiovascular disease: Implications of the results of the Women's Health Initiative. Arteriosclerosis, Thrombosis, and Vascular Biology, 23(1), 11–16.

Mahdy Ali, K., Wonnerth, A., Huber, K., & Wojta, J. (2012). Cardiovascular disease risk reduction by raising HDL cholesterol--current therapies and future opportunities. British Journal of Pharmacology, 167(6), 1177–1194.

Manolio, T. A., Pearson, T. A., Wenger, N. K., Barrett-Connor, E., Payne, G. H., & Harlan, W. R. (1992). Cholesterol and heart disease in older persons and women. Review of an NHLBI workshop. Annals of Epidemiology, 2(1-2), 161–176.

McCormack, T., Dent, R., & Blagden, M. (2016). Very low LDL-C levels may safely provide additional clinical cardiovascular benefit: the evidence to date. International Journal of Clinical Practice, 70(11), 886–897.

Melo, C., Delafiori, J., Dabaja, M. Z., de Oliveira, D. N., Guerreiro, T. M., Colombo, T. E., Nogueira, M. L., Proenca-Modena, J. L., & Catharino, R. R. (2018). The role of lipids in the inception, maintenance and complications of dengue virus infection. Scientific Reports, 8(1), 11826.

Nordestgaard, B. G., & Varbo, A. (2014). Triglycerides and cardiovascular disease. Lancet, 384(9943), 626–635.

Osuna-Ramos, J. F., Reyes-Ruiz, J. M., & Del Ángel, R. M. (2018). The role of host cholesterol during flavivirus infection. Frontiers in Cellular and Infection Microbiology, 8, 388.

Pérez-Torres, I., Guarner-Lans, V., Soria-Castro, E., Manzano-Pech, L., Palacios-Chavarría, A., Valdez-Vázquez, R. R., Domínguez-Cherit, J. G., Herrera-Bello, H., Castillejos-Suastegui, H., Moreno-Castañeda, L., Alanís-Estrada, G., Hernández, F., González-Marcos, O., Márquez-Velasco, R., & Soto, M. E. (2021). Alteration in the lipid profile and the desaturases activity in patients with severe pneumonia by SARS-CoV-2. Frontiers in Physiology, 12, 667024.

Ravi, K., Kumar, N. K., & Malagi, A. D. (2021). The lipid profile as a marker for predicting the severity of Dengue fever. International Journal of Advances in Medicine, 8(5), 691.

Sakellarios, A. I., Papafaklis, M. I., Siogkas, P., Athanasiou, L. S., Exarchos, T. P., Stefanou, K., Bourantas, C. V., Naka, K. K., Michalis, L. K., Parodi, O., & Fotiadis, D. I. (2013). Patient-specific computational modeling of subendothelial LDL accumulation in a stenosed right coronary artery: effect of hemodynamic and biological factors. American Journal of Physiology. Heart and Circulatory Physiology, 304(11), H1455–H1470.

Thejaswini, M., Kudru, C. U., Nagiri, S. K., Chakraborty, A., & Guddattu, V. (2021). Serum lipid profile in dengue patients: a simple laboratory tool to predict disease severity. Biomedicine, 41(2), 227-232.

WHO (2011). Dengue fever. World Health Organization. Retrieved August 25, 2022, from

WHO (2022). Dengue and severe dengue. World Health Organization. Retrieved August 25, 2022, from

Most read articles by the same author(s)